Rom Eliaz
Technik-/Wissenschafts-/F&E-Leiter bei Albaad Ltd.
Profil
Rom E.
Eliaz is currently the Chief Technology Officer at Albaad Ltd.
He previously served as President & Chief Executive Officer at Imcure Therapeutics, Inc., Chief Executive Officer at SciSparc Ltd., Chief Executive Officer & Managing Director at Elrom Ventures Corp., and held various directorial positions at Pfizer Inc., Intradigm Corp., Avanyx Therapeutics, Inc., Boston Therapeutics, Inc., Oxygen Therapy, Inc., and The Colmen Group, Inc. He holds undergraduate, graduate, and doctorate degrees from Ben-Gurion University of the Negev, a doctorate degree from Weizmann Institute of Science, and an MBA from Harvard Business School.
Aktive Positionen von Rom Eliaz
| Unternehmen | Position | Beginn |
|---|---|---|
Albaad Ltd.
 Albaad Ltd. Household/Personal CareConsumer Non-Durables Albaad Ltd. manufactures wet wipes and feminine hygiene products. The private company is based in Old Lyme. The CEO of the American company is Dan F. Mesika. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Rom Eliaz
| Unternehmen | Position | Ende |
|---|---|---|
| IR-MED INC. | Vorstandsvorsitzender | 30.04.2022 |
| NANOMIX CORPORATION | Direktor/Vorstandsmitglied | 16.06.2017 |
Avanyx Therapeutics, Inc.
 Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | Direktor/Vorstandsmitglied | 30.11.2010 |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.10.2007 |
| PFIZER, INC. | Corporate Officer/Principal | 01.12.2006 |
Ausbildung von Rom Eliaz
| Ben-Gurion University of the Negev | Doctorate Degree |
| Weizmann Institute of Science | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SCISPARC LTD. | Health Technology |
| IR-MED INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Avanyx Therapeutics, Inc.
Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | Health Technology |
Imcure Therapeutics, Inc.
 Imcure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Imcure Therapeutics, Inc. provides biopharmaceutical products. The firm develops small molecule therapeutics to treat diseases. The company was founded by Joseph Rubinfeld in December 2003 and is headquartered in San Francisco, CA. | Health Technology |
The Colmen Group, Inc.
 The Colmen Group, Inc. Investment Banks/BrokersFinance The Colmen Group, Inc. provides business services. It offers investment banking and consulting services with a focus on both mergers and acquisitions and corporate finance. The company was founded by Peter C. Colella, Jr. in 1981 and is headquartered in Radnor, PA. | Finance |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
| Elrom Ventures Corp. | |
Albaad Ltd.
Albaad Ltd. Household/Personal CareConsumer Non-Durables Albaad Ltd. manufactures wet wipes and feminine hygiene products. The private company is based in Old Lyme. The CEO of the American company is Dan F. Mesika. | Consumer Non-Durables |
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Health Technology |